Clinical Study

Investigation on Carbohydrate Counting Method in Type 1 Diabetic Patients

Table 2

The progress of the metabolic markers of the patients in the carbohydrate counting group.

Carbohydrate counting group () values
Pre-treatment baseline valuesValues at 6 months

TA (mmHg) = 0.065
 Systolic 109.77 ± 5.24 122.04 ± 2.60 ( > 0.05)
 Diastolic74.09 ± 1.6379.54 ± 0.72 = 0.005
()
Fasting blood glucose (mg/dL)149.63 ± 17.65160.40 ± 19.00 = 0.630
( > 0.05)
Post-prandial blood glucose (mg/dL)174.59 ± 15.46169.27 ± 8.05 = 0.710
( > 0.05)
HbA1c (%)8.14 ± 0.488.00 ± 0.38 = 0.699
( > 0.05)
Fructosamine (mg/dL)417.77 ± 22.56404.90 ± 23.59 = 0.525
( > 0.05)
Uri acid (mg/dL)3.43 ± 0.263.94 ± 0.30 = 0.003
()
Total cholesterol (mg/dL)174.50 ± 8.24170.77 ± 6.41 = 0.534
( > 0.05)
Triglyceride (mg/dL)79.04 ± 6.8375.90 ± 5.87 = 0.587
( > 0.05)
HDL cholesterol (mg/dL)71.18 ± 4.1967.40 ± 3.44 = 0.112
( > 0.05)
LDL cholesterol (mg/dL)84.49 ± 7.0192.86 ± 6.01 = 0.120
( > 0.05)
Total cholesterol/HDL cholesterol ratio2.52 ± 0.182.71 ± 0.18 = 0.174
( > 0.05)